Spot Trading L.L.C - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Spot Trading L.L.C ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q1 2017$170,000
+95.4%
26,255
+11.2%
0.01%
+200.0%
Q4 2016$87,000
+102.3%
23,600
+67.6%
0.00%
Q4 2015$43,000
-35.8%
14,078
-63.9%
0.00%
-100.0%
Q3 2015$67,000
-92.1%
39,018
-81.4%
0.00%
-87.5%
Q2 2015$852,000
+150.6%
209,800
+136.5%
0.01%
+166.7%
Q1 2015$340,000
+47.2%
88,700
+76.2%
0.00%
+200.0%
Q4 2013$231,000
-43.8%
50,348
-23.9%
0.00%
-50.0%
Q3 2013$411,000
+123.4%
66,164
+96.0%
0.00%
+100.0%
Q2 2013$184,00033,7630.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders